Search research articles
Contact Us
Filters
Showing results (121-130 of 307) with videos related to
Page
of 31
Sort By:
The Oncologist
|
July 12, 2021
Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies
Xuguang Chen, Khadija Sheikh, Erica Nakajima, et al.
Antimicrobial Agents and Chemotherapy
|
May 6, 2026
Evaluating the efficacy of ceftazidime/avibactam plus amikacin combination therapy as a carbapenem-sparing agent against ceftazidime/avibactam-resistant <i>Escherichia coli</i> using a hollow fiber infection model: a proof-of-concept study
Mikaela M Walker, Jason A Roberts, Yixuan Li, et al.
Journal of Chromatography
|
February 22, 1991
Purification of a hybrid plasminogen activator protein
J Deistung, D M Forde, J P O'Connell, et al.
Open Forum Infectious Diseases
|
October 23, 2025
Snapshot Genomic Surveillance Reveals Insights into Antimicrobial Resistance and Lineage Diversity of Uropathogens in Older Adults in Queensland
Budi Permana, Caitlin Falconer, Johanna Mayer-Coverdale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2017
Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities
Christina S Baik, Eric H Rubin, Patrick M Forde, et al.
Oncology (Williston Park, N.Y.)
|
April 24, 2018
Systemic Treatment Options for Brain Metastases from Non-Small-Cell Lung Cancer
Ajaz Bulbul, Patrick M Forde, Ayesha Murtuza, et al.
Plos Neglected Tropical Diseases
|
October 12, 2023
Melioidosis Queensland: An analysis of clinical outcomes and genomic factors
Ian Gassiep, Delaney Burnard, Budi Permana, et al.
Seminars in Arthritis and Rheumatism
|
March 26, 2018
Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen
Laura C Cappelli, Julie R Brahmer, Patrick M Forde, et al.
RMD Open
|
September 12, 2022
Anti-RA33 antibodies are present in a subset of patients with immune checkpoint inhibitor-induced inflammatory arthritis
Laura C Cappelli, Clifton O Bingham, Patrick M Forde, et al.
Microbiology Spectrum
|
May 16, 2023
Using Genomics To Investigate an Outbreak of Vancomycin-Resistant Enterococcus faecium ST78 at a Large Tertiary Hospital in Queensland
Budi Permana, Patrick N A Harris, Naomi Runnegar, et al.
Page
of 31
Search research articles
Search
Showing results (121-130 of 307) with videos related to
Sort By:
Page
of 31
The Oncologist
|
July 12, 2021
Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies
Xuguang Chen, Khadija Sheikh, Erica Nakajima, et al.
Antimicrobial Agents and Chemotherapy
|
May 6, 2026
Evaluating the efficacy of ceftazidime/avibactam plus amikacin combination therapy as a carbapenem-sparing agent against ceftazidime/avibactam-resistant <i>Escherichia coli</i> using a hollow fiber infection model: a proof-of-concept study
Mikaela M Walker, Jason A Roberts, Yixuan Li, et al.
Journal of Chromatography
|
February 22, 1991
Purification of a hybrid plasminogen activator protein
J Deistung, D M Forde, J P O'Connell, et al.
Open Forum Infectious Diseases
|
October 23, 2025
Snapshot Genomic Surveillance Reveals Insights into Antimicrobial Resistance and Lineage Diversity of Uropathogens in Older Adults in Queensland
Budi Permana, Caitlin Falconer, Johanna Mayer-Coverdale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2017
Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities
Christina S Baik, Eric H Rubin, Patrick M Forde, et al.
Oncology (Williston Park, N.Y.)
|
April 24, 2018
Systemic Treatment Options for Brain Metastases from Non-Small-Cell Lung Cancer
Ajaz Bulbul, Patrick M Forde, Ayesha Murtuza, et al.
Plos Neglected Tropical Diseases
|
October 12, 2023
Melioidosis Queensland: An analysis of clinical outcomes and genomic factors
Ian Gassiep, Delaney Burnard, Budi Permana, et al.
Seminars in Arthritis and Rheumatism
|
March 26, 2018
Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen
Laura C Cappelli, Julie R Brahmer, Patrick M Forde, et al.
RMD Open
|
September 12, 2022
Anti-RA33 antibodies are present in a subset of patients with immune checkpoint inhibitor-induced inflammatory arthritis
Laura C Cappelli, Clifton O Bingham, Patrick M Forde, et al.
Microbiology Spectrum
|
May 16, 2023
Using Genomics To Investigate an Outbreak of Vancomycin-Resistant Enterococcus faecium ST78 at a Large Tertiary Hospital in Queensland
Budi Permana, Patrick N A Harris, Naomi Runnegar, et al.
Page
of 31